Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short term Debt (2018 - 2019)

Historic Short term Debt for Sunshine Biopharma (SBFM) over the last 2 years, with Q3 2019 value amounting to $27541.0.

  • Sunshine Biopharma's Short term Debt changed N/A to $27541.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $27541.0, marking a year-over-year change of. This contributed to the annual value of $20871.0 for FY2018, which is N/A changed from last year.
  • Per Sunshine Biopharma's latest filing, its Short term Debt stood at $27541.0 for Q3 2019.
  • In the past 5 years, Sunshine Biopharma's Short term Debt registered a high of $59558.0 during Q1 2019, and its lowest value of $20871.0 during Q4 2018.